Jentzen, W., Hobbs, R. F., Stahl, A., Knust, J., Sgouros, G., & Bockisch, A. (2010). Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer.
Citación estilo ChicagoJentzen, Walter, Robert F. Hobbs, Alexander Stahl, Jochen Knust, George Sgouros, y Andreas Bockisch. Pre-therapeutic (124)I PET(/CT) Dosimetry Confirms Low Average Absorbed Doses Per Administered (131)I Activity to the Salivary Glands in Radioiodine Therapy of Differentiated Thyroid Cancer. 2010.
Cita MLAJentzen, Walter, et al. Pre-therapeutic (124)I PET(/CT) Dosimetry Confirms Low Average Absorbed Doses Per Administered (131)I Activity to the Salivary Glands in Radioiodine Therapy of Differentiated Thyroid Cancer. 2010.